Hospices Civils Strasbourg
Recent studies from France and the United Kingdom add new data to neurology research
Published in Lab Law Weekly, June 23rd, 2006
Study 1: Three patients with amyotrophic lateral sclerosis (ALS) and a polyneuropathy resembling chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) may help elucidate disease pathogenesis.
"We report three patients with a syndrome that fulfilled clinical and laboratory criteria for definite CIDP who failed immunosuppressive treatment and eventually developed progressive ALS. Mean disease duration was 23 months (13-38) before death," scientists in France reported.
"Two patients had a family history of ALS without mutations of the SOD1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-06-23)
More Articles from Lab Law Weekly
- Aegate
Pilot study confirms use of Aegate's technology to combat pharmaceutical fraud - Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals to acquire Quill Medical - Biotechnology Industry Organization
BIO names Tom DiLenge as general counsel - Chimerix, Inc.
Chimerix acquires lead compound library of antiviral agents from University of Michigan - Elsevier MDL
Electronic laboratory notebooks for chemistry and biology are reviewed - ExonHit Therapeutics
ExonHit files patent on a panel of genes for the diagnosis of Alzheimer disease from blood - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
